Leadership Team

The Leadership Team at Lycia Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative lysosomal targeting chimeras (LYTAC) therapies. This team, comprised of top executives including the President & CEO and Chief Scientific Officers, collaborates closely to drive research initiatives, ensure operational excellence, and foster partnerships that enhance the company's position as a leader in extracellular protein degradation.